BridgeBio
With drugs on the horizon for treating and possibly preventing transthyretin amyloid cardiomyopathy, cardiologists are weighing the pros and cons of genetic screening.
With drugs on the horizon for treating and possibly preventing transthyretin amyloid cardiomyopathy, cardiologists are weighing the pros and cons of genetic screening.